Basilea Pharmaceutica Ltd, Allschwil header image

Basilea Pharmaceutica Ltd, Allschwil

BSLN

Equity

ISIN CH0011432447 / Valor 1143244

SIX Swiss Exchange (2026-10-16)

CHF 65.60-4.37%

Basilea Pharmaceutica Ltd, Allschwil
UMushroom community rating:

3.29 3 votes No rating yet

NegativeNeutralPositive

About company

Basilea Pharmaceutica Ltd, based in Allschwil, Switzerland, is a commercial-stage biopharmaceutical company listed on the SIX Swiss Exchange under the ticker BSLN. The company specializes in the research, development, and commercialization of innovative pharmaceutical products, primarily focusing on anti-infective therapies. Basilea aims to address significant medical challenges by developing treatments for serious and life-threatening conditions. Its strategic focus on anti-infectives positions it to tackle pressing global health issues, such as antibiotic resistance and the need for effective antifungal treatments. Through its commitment to advancing medical science, Basilea seeks to provide solutions that improve patient outcomes in critical care settings.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

34.2%1Y

69.7%3Y

52.3%5Y

Performance

27.7%1Y

29.7%3Y

31.3%5Y

Volatility

987 M

Market cap (USD)

25,814

Daily traded volume (Shares)

42.05 / 40.85

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.29

3 votes

Performance:

3.14

Innovation:

3.57

Society:

3.57

Nature:

3.57

Filippo Scacchi

Switzerland, 22 Mar 2026

Watch out

Camilla Mossetti

Switzerland, 21 Mar 2026

Good performance lately

N K

Switzerland, 26 Mar 2025

.

EQUITIES OF THE SAME SECTOR

NATCO Pharma Limited

NATCO Pharma Limited Valor: 30461955

Annual Return

-50%0%+50%

Risk level

110

0.06%INR 785.25

Granules India Limited

Granules India Limited Valor: 27420047

Annual Return

-50%0%+50%

Risk level

110

1.57%INR 825.70

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited Valor: 11500585

Annual Return

-50%0%+50%

Risk level

110

-0.40%INR 788.40

Narayana Hrudayalaya Ltd.

Narayana Hrudayalaya Ltd. Valor: 30795490

Annual Return

-50%0%+50%

Risk level

110

-0.29%INR 1,718.55

Unitedhealth Group Inc

Unitedhealth Group Inc Valor: 1078451

Annual Return

-50%0%+50%

Risk level

110

-1.29%USD 401.43

Abbott Laboratories

Abbott Laboratories Valor: 903037

Annual Return

-50%0%+50%

Risk level

110

0.20%USD 104.89

Encompass Health Corporation

Encompass Health Corporation Valor: 39085960

Annual Return

-50%0%+50%

Risk level

110

0.08%USD 127.87

RHOEN-KLINIKUM AG

RHOEN-KLINIKUM AG Valor: 341644

Annual Return

-50%0%+50%

Risk level

110

0.69%EUR 14.50

Ajanta Pharma Limited

Ajanta Pharma Limited Valor: 27480449

Annual Return

-50%0%+50%

Risk level

110

-1.11%INR 3,323.05

COSMO Pharmaceuticals N.V.

COSMO Pharmaceuticals N.V. Valor: 32590356

Annual Return

-50%0%+50%

Risk level

110

0.00%CHF 51.90

SIX

FactSet

Clearbit

Logos provided by Clearbit